Triple Strength Fish Oil plus Joint
GNC Triple Strength Fish Oil plus Joint supports joint health and mobility. This supplement provides Omega-3 fatty acids, EPA, and DHA, along with Levagen and ApresFlex Boswellia serrata for comprehensive joint support. Ideal for individuals seeking to maintain joint comfort and flexibility.
About This Product
Triple Strength Fish Oil plus Joint by GNC is a omega & fish oil supplement containing 9 active ingredients. It has earned an N+ Score of 85/100 (Grade B+).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Eicosapentaenoic Acid, Docosahexaenoic Acid.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Comprehensive formula with expected ingredients for its category
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +2 ingredient(s) at clinical dose levels
Weaknesses
- −No major weaknesses identified
Ingredient Analysis (9 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 15.000 Calorie(s) | N/A |
| Total Fat | 1.500 Gram(s) | N/A |
| Eicosapentaenoic Acid | 734.000 mg | Optimal |
| Docosahexaenoic Acid | 267.000 mg | Adequate |
| Total Omega-3 Fatty Acids | 1065.000 mg | N/A |
| Other Omega-3 Fatty Acids | 65.000 mg | N/A |
| Total EPA + DHA | 1000.000 mg | N/A |
| Levagen Palmitic Acid Monoethanolamide | 300.000 mg | N/A |
| ApresFlex Boswellia serrata gum extract | 100.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
